Filings #1: Federal Energy's Ultimate Non-Event Announcement
Published Date: 8/5/2026
Notice
Summary
No summary available.
No Economic Impacts Identified for this Document
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-22879, Combined Notice of Filings #1
The Federal Energy Regulatory Commission got several new filings from energy companies like ATCO, Emera, and Google Energy. These filings include requests for approvals, complaints, and updates on company statuses. If you’re involved or interested, note the comment deadlines in November—they could affect how energy businesses operate and possibly impact prices or services.
2026-22878, ConocoPhillips Company; Notice of Institution of Section 206 Proceeding and Refund Effective Date
The Federal Energy Regulatory Commission is investigating whether ConocoPhillips’ electricity rates are fair or not. If found unfair, refunds could be required starting from November 10, 2026. Anyone interested has 21 days to join the case and share their views.
2026-22877, Combined Notice of Filings
The Federal Energy Regulatory Commission got new filings from natural gas companies about rate changes and reports. These updates could affect customers and businesses by changing pipeline rates or how penalties are handled, with some changes starting as soon as October 2026. If you want to speak up or get involved, you need to comment by specific deadlines in November or January.
2026-22803, Northern Illinois Hydropower, LLC; Notice of Request for Extension of Time To Commence and Complete Construction Accepted for Filing, Soliciting Comments, Motions To Intervene, and Protests
Northern Illinois Hydropower, LLC asked for more time to start and finish building their Brandon Road Hydroelectric Project in Illinois. The project sits on federal land near Rockdale and needs approval from the Federal Energy Regulatory Commission (FERC). People have until December 4, 2026, to share their thoughts or objections, so this extension could affect the project’s timeline and future energy plans.
2026-22791, Combined Notice of Filings
The Federal Energy Regulatory Commission got new filings about natural gas pipeline rates from Texas Eastern Transmission and Enable Gas Transmission. These filings propose changes to contracts and rates starting November 1 or 5, 2026, which could affect customers and companies using these pipelines. If you want to speak up or get involved, you need to act by November 16, 2026.
2026-22721, Transcontinental Gas Pipe Line Company, LLC; Notice of Schedule for the Preparation of an Environmental Assessment for the Leidy Access Expansion Project
Transcontinental Gas Pipe Line Company wants to build new pipeline facilities in Pennsylvania to move more natural gas from the Marcellus Shale area. The government is preparing an environmental review to make sure the project is safe and will finish it by March 26, 2027. If all goes well, final approvals should happen by June 24, 2027, affecting local communities and energy customers with potential new energy options.
Previous / Next Documents
Previous: 2026-15884, Columbia Gas Transmission, LLC; Notice of Availability of the Environmental Assessment for the Proposed NKY Gate Enhancement Project
Next: 2026-15887, Establishment of a Quantitative Medicine Innovation Network: Scope, Feasibility, and Opportunities; Request for Information
The Center for Drug Evaluation and Research (CDER) within the Food and Drug Administration (FDA or Agency), through its Quantitative Medicine Center of Excellence (QM CoE), is announcing a request for information to inform the development of a Quantitative Medicine Innovation Network (QMIN). The vision for the QMIN is to create a cross-sector collaborative platform that accelerates the translation of quantitative medicine approaches to transform drug development, regulatory science, and clinical decision-making for patient benefit. The purpose of this request is to obtain feedback from industry, academia, healthcare providers, patient groups, and other interested parties on identifying critical community needs and establishing mechanisms for continuous engagement, supporting collaborative demonstration projects or research on innovative approaches aimed at addressing high priority areas through the application of QM approaches, and exploring mechanisms to leverage community expertise and capacity to promote QM innovation and adoption. Information submitted in response to this request will be considered in shaping the structure, priorities, and activities of the QMIN.